New trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen starts in Britain
LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc and As
Cde
